• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

FemTech: Oova Launches New Fertility Membership Model

by Jasmine Pennic 06/29/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
FemTech: Oova Launches New Fertility Membership Model

What You Should Know: 

  • Femtech solutions company OOVA launches its brand NEW fertility membership model designed to support and empower women by providing advanced at-home hormone testing and full-circle assistance along their fertility journey with unmatched ease, for only $99/mo.  
  • OOVA, the first and only OTC hormone test that quantitatively measures two essential hormones in a single, at-home urine test, provides women with insights into their ovulation patterns to increase the probability of conception. 

The OOVA Fertility Membership

Only 1 in 10 women flow on a 28-day cycle, and monitoring + understanding your cycle patterns can take months and requires more than a single at-home test. Current at-home ovulation trackers operate on that baseline, consequently providing false-positive and futile results. OOVA is FDA-registered, HIPAA compliant, and the only test on the market to measure luteinizing hormone (LH) and progesterone (PdG) in real-time, providing women with daily insights and actionable advice to optimize their chances of conception.

The new OOVA fertility membership includes: 

  • Monthly supply of 15 test sticks
    • Measuring 30 hormones with lab-quality accuracy
  • Access to the OOVA provider network
    • Experienced healthcare providers and 1:1 consultations with OOVA’s hormone experts to help you turn data into actionable insights
  • Sync + share results with your doctor in real time 
    • The HIPAA compliant platform allows your doctor to access your hormone results virtually. 
    • The average doctor’s appointment is 6.5 minutes long. Coming to your appointment armed with data allows you to advocate for yourself and streamline your journey to conception. 
  • Support within the OOVA community + Monthly webinars
    • Connect with other women on their own fertility journeys for a support system of people who understand infertility struggles.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |